Back to today’s briefing

Story perspectives

Kennedy Panel Endorses RSV Treatment for Infants

6/27/2025

49 8

Summary

Kennedy Endorses Enflonsia

Robert F. Kennedy Jr.'s vaccine advisory panel has taken a bold step by endorsing Merck's Enflonsia monoclonal antibody for infants under eight months, aiming to combat the dangerous respiratory syncytial virus (RSV). Despite some skepticism among panel members, this recommendation could be a game-changer for the thousands of infants hospitalized each year due to RSV.

Summary

Kennedy Sparks Controversy

Robert F. Kennedy Jr.'s vaccine advisory panel convened for its inaugural meeting, igniting alarm among public health experts. The panel's review of established vaccine schedules, like those for hepatitis B and measles, has drawn criticism for its members' perceived lack of expertise. The American Academy of Pediatrics has labeled the committee as "illegitimate," raising fears about potential damage to public trust in vaccinations.

1 of 2

Kennedy Endorses Enflonsia

Robert F. Kennedy Jr.'s vaccine advisory panel has taken a bold step by endorsing Merck's Enflonsia monoclonal antibody for infants under eight months, aiming to combat the dangerous respiratory syncytial virus (RSV). Despite some skepticism among panel members, this recommendation could be a game-changer for the thousands of infants hospitalized each year due to RSV.

1 / 2